Who Is Carrying the Fear

Start with the structural fact, because everything else on this page follows from it. In Japan the dominant method of contraception, by a very wide margin, is the condom — which is to say that the dominant method in this country is the one the other person puts on, and can decline to.

Say that plainly and a great deal stops being mysterious. Why the conversation happens in the dark at the wrong moment. Why "it’s fine, I’ll be careful" is a sentence so many women have had to negotiate with while in no position to negotiate. Why the low background hum of what-if never quite goes away, even in a long relationship with someone kind.

This page has three jobs. To set out what actually exists here, since several good options are less known than they should be. To answer the libido question honestly, including where the evidence is genuinely unclear. And to make an argument nobody makes: that for most women, what contraception does to desire has less to do with hormones than with the removal of a background fear — and that this is a reason to take the decision seriously as an intimacy question, not only as a risk question.

The low-dose contraceptive pill was approved in Japan in 1999, after roughly nine years of official deliberation about whether it was appropriate. Most comparable countries had approved a pill decades earlier. The Japan & Women shelf has a page that sets that date beside another approval in the same year, and this page will not repeat the comparison because the other one makes it better.

What matters here is the shape of the delay rather than its length. The deliberation was conducted largely by men, in committees, about whether Japanese women could be trusted with a method they controlled themselves, with arguments that ranged over public morals and the fear that condom use would fall. The people whose bodies were under discussion were not, in any meaningful sense, in the room.

The consequences ran for decades and some are still running. Uptake of the pill in Japan has remained low by international comparison. Emergency contraception stayed behind a prescription — and therefore behind a clinic’s opening hours — long after most peer countries moved it to a pharmacy counter, with over-the-counter availability here only beginning through trials from 2023, at the precise point in a person’s life when hours matter more than almost anything.

None of that is a fact about Japanese women’s preferences. It is the residue of decisions taken by people who were not going to be pregnant, and knowing it is the residue rather than the nature of things is worth something — because a residue can be walked around by anybody who knows it is there.

Not a recommendation — a map. Which of these suits any particular person is a conversation with a 婦人科, and this shelf has a page about what that appointment is actually like.

Low-dose combined pills — 低用量ピル — taken daily. Highly effective when taken consistently, and prescribed here for symptoms as often as for contraception: heavy bleeding, severe period pain, cycle irregularity, endometriosis. A woman who does not need contraception may still be a candidate, which a great many never learn because they assume the category is about preventing pregnancy.

Hormonal intrauterine systems — ミレーナ and similar — placed by a doctor and lasting several years. Very effective, and they frequently reduce bleeding markedly, which is why they are often prescribed for heavy periods. Once placed, nothing is required daily and nothing is required at the moment. For many women that second property is the whole point.

Copper intrauterine devices, for anybody who wants effectiveness without hormones. Emergency contraception — アフターピル — most effective the sooner it is taken, available by prescription and, increasingly, at participating pharmacies. It is worth finding out now where you would get it, because the one thing certain about needing it is that you will not want to be researching at that moment.

And the method that is dominant here: condoms, which remain the only common method that also reduces transmission of infection — a genuine advantage that no hormonal method has, and a reason many people use two things rather than one. Their weakness is not effectiveness in theory but that correct use depends on somebody else at the moment it matters.

Cost keeps more women off these methods than side effects do, and there is one distinction inside it that is worth more than everything else on this page put together.

A pill prescribed for contraception is 自費 — outside insurance, paid in full, typically a few thousand yen a month. A pill prescribed for a medical indication — 月経困難症, endometriosis, heavy bleeding — can be 保険適用, covered, at a fraction of that. These are frequently the same drug. What differs is the reason written on the prescription.

This is not a loophole and there is nothing to game. If you have painful or heavy periods — and a very large share of women do, and have spent years assuming it was simply their lot — then that is a medical indication, it is the true reason, and saying it at the appointment is simply accurate. An enormous number of women have gone without because they costed the 自費 version and stopped there, never having been told the other column existed.

The intrauterine systems work the same way: placed for contraception they are a one-off self-paid cost in the tens of thousands of yen, and placed for heavy bleeding they can be covered. Spread over the years one lasts, even the self-paid version is often cheaper per month than a daily pill, which surprises people who have only ever compared the upfront numbers.

And access has genuinely improved in one respect worth knowing: online consultation — オンライン診療 — is now widely available for this, with the prescription posted. For a woman whose obstacle was never the medicine but a clinic open exactly when she is at work, that removes the actual barrier rather than the imagined one.

Does hormonal contraception reduce desire? It is the question women ask most and get a straight answer to least, usually because the honest answer is unsatisfying and people prefer a clean one.

The honest answer: the evidence is genuinely mixed. Some people report a fall, some report a rise — often because the fear of pregnancy lifted — and most report no clear change. Studies disagree with each other, the effects that do appear are small at the group level, and the between-person variation is large. Anybody telling you confidently that the pill kills desire, or that it definitely does not, is reporting their own experience or their politics rather than the literature.

What is defensible and actually useful: if your desire changed markedly and durably after starting a particular method, that is worth raising with a prescriber rather than absorbing. There are several formulations with different hormonal profiles, there are non-hormonal options, and switching is ordinary. A woman who assumes she must simply live with it is doing the thing this whole shelf argues against — converting an adjustable variable into a fixed fact about herself.

And one confound worth naming, because it is probably responsible for a share of the reported falls. People frequently start hormonal contraception at a particular moment in a relationship, and relationships have their own trajectory of desire that has nothing to do with a tablet. The pill gets the blame for a second year that was going to be quieter than the first regardless. That is not an argument that the effect is imaginary; it is an argument for keeping a record before concluding, which is the same advice this shelf gives about the cycle.

Here is the argument this page exists to make, and it is missing from almost every discussion of contraception, which treats the subject purely as risk management.

This shelf argues at length that desire for most women is responsive: it arrives after good conditions rather than before them. Now ask what a background fear of pregnancy does inside that model. It is not neutral. It is a condition — a constant, low-level cost running underneath everything, taking attention, keeping a part of the mind in the room as an observer doing arithmetic about dates.

Remove it and you have not merely removed a worry. You have changed one of the conditions the whole system runs on. A great many women who switch to a method they control themselves describe the change in exactly these terms — not that they suddenly wanted more, but that something that had been quietly taxing every occasion stopped. That is a larger and more reliable effect than anything the hormonal literature can pin down, and it is almost never counted, because it does not look like a medical variable.

Which makes contraception a question about intimacy and not only about risk, and it makes the choice of method a question about who is carrying the fear. A method the other person operates leaves the fear with you. A method you operate moves it. That is not a statement about anybody’s trustworthiness — it is a statement about where a cost sits, and costs sit where the mechanism puts them regardless of how much anybody loves anybody.

The structural problem with condom-dominance is not the condom. It is that the decision gets made at the least negotiable moment available — undressed, mid-way, with the whole evening apparently at stake if you say the wrong thing.

So move it. A conversation about contraception is a conversation to have with clothes on, in daylight, over something else — and framed as logistics rather than as trust, because a trust frame invites a defence and a defence ends it. "I want to sort out what we’re using, properly, rather than deciding it every time" is a sentence about admin. "I don’t trust you to" is a sentence about him, and you will spend the next hour on his feelings instead of on the question.

And the sentence to have ready for the moment itself, because the moment will still come: no is a complete answer and does not require a reason. "I’m not doing that without one" needs no justification, no apology and no negotiation, and a person who argues with it after you have said it once has told you something useful about himself that is worth knowing early.

It is also worth deciding in advance what you will do if a method fails, because the worst time to work that out is the morning it happens. Know where emergency contraception is available near you and what the hours are; know that sooner is better and that the window is measured in days rather than weeks; and if you are in a relationship, having said once, calmly, on an ordinary evening, what the two of you would do — rather than discovering your positions differ during the crisis itself — is one of the more useful conversations a couple can have and one of the least often had.

One thing that is not a contraceptive method, since it is treated as one by a startling number of couples: withdrawal. Its real-world failure rate is high, and "I’ll be careful" is not a plan. If that is what is currently in use, that is worth knowing plainly rather than politely.

A reader deserves to know the legal situation accurately, so this section states it and does not argue about it.

Abortion in Japan is governed by the 母体保護法 rather than by a general right, is permitted on specified grounds including economic ones, and is time-limited. The feature that distinguishes Japan from most peer countries is the spousal consent requirement: where a woman is married, the law has been read as requiring the consent of her spouse. Guidance has narrowed this — including in circumstances involving violence or where the spouse’s whereabouts are unknown — but the requirement remains widely believed to apply more broadly than it does, and that belief has its own effects.

Medical abortion — the pill-based method standard in many countries for early termination — was approved in Japan only in 2023, decades after elsewhere, and its availability remains limited in practice. Surgical methods have accordingly been the norm here far longer than in peer countries.

This page takes no position on any of that. It states it because a woman making decisions about contraception is entitled to know what the fallback actually looks like in her own country, and because a very large number of people here hold beliefs about this law that are out of date in both directions.

Nothing on this page is a Moonlight matter. Prescribing is a 婦人科; the legal position is a lawyer or a municipal service; the choice of method is between a woman and her doctor, and this house has no view worth having about which one.

The one thing genuinely ours is the argument in the middle of the page, because it is an argument about attention rather than about medicine. A background fear is a condition, conditions are what responsive desire runs on, and a house that talks about presence while ignoring the largest standing distraction in a woman’s intimate life would be talking about presence dishonestly.

Which also has a plain operational consequence here. Moonlight’s Experiences do not involve intercourse, so the question does not arise in the room — and that is not a marketing line, it is the reason a particular kind of attention is possible in it at all. Nothing is being risked, so nothing is being monitored, and a nervous system with nothing to monitor is doing something different from one that is.

The dominant method in this country is one somebody else operates, and the argument about giving women a method of their own was held over nine years, largely without them, and settled in 1999.

You do not have to carry the residue of that. Find out what exists, ask about it at an appointment you were entitled to anyway, and notice — this is the part worth noticing — how much of what you had filed under "I am just not very interested" turns out to have been a cost you were quietly paying every single time. Fear is not a personality. It is a condition, and conditions can be changed.